Baltimore, Maryland / February 25, 2014 / Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, announced today that it has issued a research update on MediSwipe, Inc. (OTCQX – MWIP), a provider of innovative patient solutions, and the leader in Compassionate Care Technology for the medicinal marijuana industry.
The medical marijuana and recreational marijuana industries are in the early innings of a major adoption phase which are expected to result in $20 billion in revenue in the coming years. Approved in 20 states and D.C., and with endorsements from high profile doctors such as Dr. Sanjay Gupta, more states will soon come on line increasing the size of the market.
In the Goldman Opportunity Research update on the Company, analyst Rob Goldman outlines his investment thesis.
“Despite approval in 20 states and D.C., medical marijuana (and recreational marijuana) dispensaries have been forced to conduct cash-only business due to age-old regulations prohibiting banks from doing business with such entities. In the first of what is likely to be a series of dramatic shifts, the federal government finally gave banks a road map for conducting transactions with legal marijuana sellers so these new businesses can operate like any other enterprise, including paying taxes. One of the biggest hurdles in the medical marijuana and recreational marijuana industries is now changing for the better which, when finalized, will have a profoundly positive impact on MediSwipe.”
This press release contains excerpts of our most recently published sponsored article on MediSwipe, Inc. Goldman Small Cap Research sponsored articles, reports, and updates as well as associated disclaimers and disclosures can be accessed or downloaded in their entirety by visiting http://www.goldmanresearch.com/.
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and micro cap stock research reports, articles, daily stock market blogs, and popular investment newsletters. Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.
A Goldman Small Cap Research report, update, newsletter, or article is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download our research, view our disclosures, or for more information, visit http://www.goldmanresearch.com/.
About MediSwipe, Inc.: MediSwipe Inc. (OTCQX – MWIP) provides innovative patient solutions and is the leader in Compassionate Care Technology for the medicinal marijuana industry. MediSwipe provides terminal-based service packages and integrated Web Portal add-ons for physicians, clinics, hospitals and medical dispensaries that include: digital patient records, Electronic Referrals, Credit/Debit Card merchant services, and health and wellness product lines including beverages, vaporizers and accessories. For more information, please visit http://www.MediSwipe.com.
Goldman Small Cap Research
Rob Goldman, Analyst
- medicinal marijuana